News
AXGN
44.57
-3.05%
-1.40
Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD), AxoGen (AXGN) and Eli Lilly & Co (LLY)
TipRanks · 1d ago
Weekly Report: what happened at AXGN last week (0629-0703)?
Weekly Report · 1d ago
Weekly Report: what happened at AXGN last week (0622-0626)?
Weekly Report · 06/29 09:19
10 mid-cap U.S. healthcare stocks with the strongest momentum grades
Seeking Alpha · 06/24 13:45
AxoGen Shareholders Approve Directors, Auditor and Executive Pay
TipRanks · 06/23 22:00
Axogen shareholders elected eight directors at annual meeting
PUBT · 06/23 20:40
Weekly Report: what happened at AXGN last week (0615-0619)?
Weekly Report · 06/22 09:21
AxoGen’s New Head-to-Head Nerve Repair Study Puts Avance Graft Under the Spotlight
TipRanks · 06/18 16:33
Weekly Report: what happened at AXGN last week (0608-0612)?
Weekly Report · 06/15 09:21
Weekly Report: what happened at AXGN last week (0601-0605)?
Weekly Report · 06/08 09:20
Weekly Report: what happened at AXGN last week (0525-0529)?
Weekly Report · 06/01 09:21
Weekly Report: what happened at AXGN last week (0518-0522)?
Weekly Report · 05/25 09:22
Weekly Report: what happened at AXGN last week (0511-0515)?
Weekly Report · 05/18 09:22
AxoGen Director Makes Notable Insider Move With Fresh Stock Sale
TipRanks · 05/13 02:12
Axogen director Amy McBride-Wendell disposes 1,647 shares worth $70,162.2
PUBT · 05/12 20:07
Weekly Report: what happened at AXGN last week (0504-0508)?
Weekly Report · 05/11 09:21
AxoGen Insiders Quietly Unload a Wave of Shares in Major Cash-Out Spree
TipRanks · 05/09 02:05
Axogen director John Johnson disposes of 11,050 shares worth $478,966.75
PUBT · 05/08 20:10
Axogen director Kathy Johnson Weiler disposes 16,344 shares for $720,448.7
PUBT · 05/08 20:10
Axogen CMO Jens Kemp disposes 4,000 shares worth $173,761.20
PUBT · 05/08 20:09
More
Webull provides a variety of real-time AXGN stock news. You can receive the latest news about Axogen Inc through multiple platforms. This information may help you make smarter investment decisions.
About AXGN
Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel.